Recombinant adenoviral vector expressing HCV NS4 induces protective immune responses in a mouse model of Vaccinia-HCV virus infection: A dose and route conundrum-Reference-Cited by-同舟云学术

Recombinant adenoviral vector expressing HCV NS4 induces protective immune responses in a mouse model of Vaccinia-HCV virus infection: A dose and route conundrum

Published:2014-05 Issue:23 Volume:32 Page:2712-2721
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Singh Shakti,Vedi Satish,Li Wen,Samrat Subodh Kumar,Kumar Rakesh,Agrawal Babita

Funder

Canadian Institutes of Health Research

Heritage Foundation

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference57 articles.

1. Epidemiology of hepatitis C: geographic differences and temporal trends;Wasley;Seminars in Liver Disease,2000

2. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma;Saito;Proceedings of the National Academy of Sciences of the United States of America,1990

3. Analysis of a successful immune response against hepatitis C virus;Cooper;Immunity,1999

4. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease;Thimme;Proceedings of the National Academy of Sciences of the United States of America,2002

5. Immunology of hepatitis B virus and hepatitis C virus infection;Rehermann;Nature Reviews Immunology,2005

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucosal immunization with lipopeptides derived from conserved regions of SARS-CoV-2 antigens induce robust cellular and cross-variant humoral immune responses in mice;Frontiers in Immunology;2023-06-02

2. Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial;Human Vaccines & Immunotherapeutics;2019-10-04

3. Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens;Cells;2019-05-26

4. Development of a recombinant murine tumour model using hepatoma cells expressing hepatitis C virus nonstructural antigens;Journal of Viral Hepatitis;2018-02-21

5. Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension;International Journal of Molecular Sciences;2017-07-27